Abstract

Ocular inflammation is a common complication of various eye diseases with wide consequences from irritations to potentially sight-threatening complications. Green tea is a popular beverage throughout the world. One of the proven health benefits of consuming green tea extract (GTE) is anti-inflammation. Catechins are the biologically active constituents of GTE. In in vitro and in vivo studies, GTE and catechins present inhibition of inflammatory responses in the development of ocular inflammation including infectious, non-infectious or autoimmune, and oxidative-induced complications. Research on the ocular inflammation in animal models has made significant progress in the past decades and several key disease mechanisms have been identified. Here we review the experimental investigations on the effects of GTE and catechins on various ocular inflammation related diseases including glaucoma, age-related macular degeneration, uveitis and ocular surface inflammation. We also review the pharmacokinetics of GTE constituents and safety of green tea consumption. We discuss the insights and perspectives of these experimental results, which would be useful for future development of novel therapeutics in human.

Highlights

  • One major entity of ocular inflammation appears in uvea, which leads to uveitis, a complex group of manifestations of intraocular inflammation with variable consequences ranging from persistent irritations, pain, and vision impairment

  • We investigated the therapeutic effects of green tea extract (GTE) and epigallocatechin gallate (EGCG) in the experimental autoimmune uveoretinitis (EAU) model [55]

  • GTE suppressed the production of tumor necrosis factor-alpha (TNF-a), IL-6 and monocyte chemoattractant protein-1 (MCP-1) in the aqueous humor, which was associated with a down-regulation of LPS receptor complex subunits, Toll-like receptor 4 (TLR-4) and CD14, and suppression of nuclear factor kappa B p65 (NFkBp65) in the iris and ciliary bodies

Read more

Summary

Frontiers in Nutrition

Ocular inflammation is a common complication of various eye diseases with wide consequences from irritations to potentially sight-threatening complications. Green tea is a popular beverage throughout the world. One of the proven health benefits of consuming green tea extract (GTE) is anti-inflammation. Catechins are the biologically active constituents of GTE. In in vitro and in vivo studies, GTE and catechins present inhibition of inflammatory responses in the development of ocular inflammation including infectious, non-infectious or autoimmune, and oxidative-induced complications. We review the experimental investigations on the effects of GTE and catechins on various ocular inflammation related diseases including glaucoma, age-related macular degeneration, uveitis and ocular surface inflammation. We review the pharmacokinetics of GTE constituents and safety of green tea consumption.

Ocular Inflammation
Green Tea in Ocular Inflammation
Green Tea Catechins
PHARMACOKINETICS OF GREEN TEA CATECHINS IN OCULAR TISSUES
Green Tea Catechins in Treating Autoimmune Uveitis
Green Tea Catechins in Treating Retinal Degeneration
Effects of Green Tea Catechins in Experimental Glaucoma Models
Green Tea Catechins and Ocular Surface Inflammation
EFFECTS OF GREEN TEA AND CATECHINS ON OTHER SYSTEMIC INFLAMMATORY DISEASES
SAFETY OF GREEN TEA CONSUMPTION AND GTE ADMINISTRATION
Findings
FUTURE PERSPECTIVE AND RESEARCH OPPORTUNITIES
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call